| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.467 | 2.561 | 2.868 | 0 | 948 | 2.763 | 1.516 | 3.467 | 14.671 | 23.268 |
| Total Income - EUR | 2.467 | 2.561 | 3.334 | 1.976 | 1.950 | 4.523 | 3.033 | 4.962 | 24.538 | 32.404 |
| Total Expenses - EUR | 2.354 | 68 | 2.145 | 1.452 | 232 | 215 | 201 | 343 | 22.312 | 30.416 |
| Gross Profit/Loss - EUR | 113 | 2.492 | 1.189 | 523 | 1.718 | 4.308 | 2.832 | 4.619 | 2.226 | 1.988 |
| Net Profit/Loss - EUR | 39 | 2.416 | 1.101 | 523 | 1.689 | 4.233 | 2.787 | 4.524 | 1.980 | 1.711 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Bio Budava Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 94 | 64 | 36 | 5 | 0 | 0 | 0 | 0 | 26.680 | 26.575 |
| Current Assets | 2.638 | 2.235 | 4.364 | 4.754 | 6.356 | 10.469 | 13.110 | 15.718 | 15.334 | 7.400 |
| Inventories | 126 | 127 | 873 | 1.340 | 1.357 | 2.158 | 2.717 | 1.180 | 1.081 | 2.171 |
| Receivables | 1.089 | 162 | 1.035 | 157 | 154 | 2.914 | 1.663 | 3.486 | 3.270 | 2.378 |
| Cash | 1.423 | 1.946 | 2.456 | 3.257 | 4.846 | 5.397 | 8.730 | 11.053 | 10.983 | 2.850 |
| Shareholders Funds | -195 | 2.222 | 3.286 | 3.749 | 5.366 | 9.497 | 12.073 | 14.633 | 16.569 | 18.187 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.927 | 77 | 1.115 | 1.010 | 990 | 972 | 1.036 | 1.085 | 29.407 | 16.898 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "150 - 150" | |||||||||
| CAEN Financial Year |
150
|
|||||||||
Comments - Bio Budava Srl